Colorectal tumor prevention by the progestin medroxyprogesterone acetate is critically dependent on postmenopausal status

The large randomized placebo controlled trials of the Women’s Health Initiative have shown that the combination of estrogen and progestin medroxyprogesterone acetate (MPA) protects from colorectal cancer in postmenopausal women. No effect was observed in women treated with estrogen alone. This sugge...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Meijer, Bartolomeus J., Wielenga, Mattheus C.B., Hoyer, Patricia B., Amos-Landgraf, James M., Hakvoort, Theodorus B.M., Muncan, Vanesa, Heijmans, Jarom, van den Brink, Gijs R.
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2018
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6078141/
https://ncbi.nlm.nih.gov/pubmed/30093969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25703
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky